IDEAYA Biosciences (IDYA) Price-to-Earnings (P/E) Ratio

Price: $16.98
Market Cap: $1.49B
Avg Volume: 1.14M
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 0.506
52W Range: $13.45-44.42
Website: IDEAYA Biosciences

Price-to-Earnings (P/E) Ratio Summary

IDEAYA Biosciences's P/E ratios across different time periods:

  • TTM: -5.05
  • Annual: -7.65
  • Quarterly: -4.03

What is P/E Ratio?

The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's stock price to its earnings per share (EPS). It indicates how much investors are willing to pay for each dollar of company earnings.

Related Metrics

  • Price-to-Book (P/B) Ratio: 1.98
  • Price-to-Sales (P/S) Ratio: 299.88

Annual Ratios

IDEAYA Biosciences Historical P/E Ratio

0.000.00-1.81-1.81-3.62-3.62-5.44-5.44-7.25-7.25-9.06-9.06-10.87-10.87-12.68-12.68-14.49-14.49-16.31-16.31-18.12-18.12P/E Ratio-7.65-18.12-13.74-17.53-10.73-3.95-4.64-13.432018201820192019202020202021202120222022202320232024202420252025

Historical P/B Ratio

3.793.792.402.401.011.01-0.38-0.38-1.78-1.78-3.17-3.17-4.56-4.56-5.95-5.95-7.34-7.34-8.73-8.73-10.12-10.12P/B Ratio1.983.302.152.761.751.51-3.26-10.122018201820192019202020202021202120222022202320232024202420252025

Historical P/S Ratio

344.86344.86310.37310.37275.89275.89241.40241.40206.91206.91172.43172.43137.94137.94103.46103.4668.9768.9734.4934.490.000.00P/S Ratio299.8887.5214.7929.8317.7120212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025

TTM P/E Ratio

-5.05

P/B Ratio (Annual)

1.98

P/S Ratio (Annual)

299.88

IDEAYA Biosciences Historical Valuation Metrics

The table below shows various valuation metrics for each year, with the latest data available for the last fiscal year 2024.

Year P/E Ratio P/B Ratio P/S Ratio
2024 -7.65 1.98 299.88
2023 -18.12 3.30 87.52
2022 -13.74 2.15 14.79
2021 -17.53 2.76 29.83
2020 -10.73 1.75 17.71
2019 -3.95 1.51 0.00
2018 -4.64 -3.26 0.00
2017 -13.43 -10.12 0.00

Related Metrics

Explore detailed financial metrics and analysis for IDYA.